Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion type Assertion NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_head.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion description "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion evidence source_evidence_literature NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion SIO_000772 22988110 NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion wasDerivedFrom befree-2016 NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion wasGeneratedBy ECO_0000203 NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.